Asilomed Private Limited, a active private limited company, was established on 03 October 2020 in Hosur, Tamil Nadu, India. Engaging in lifestyle products & accessories manufacturing within the manufacturing sector, it holds CIN: U33309TN2020PTC138368. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹3.50 Cr.
Employing 15 professional, Its leadership includes Mohammed Farook Yasar Arabath (Additional Director), Vingnanamurthy Silambarasan (Additional Director), Govindasamy Dharmalingam (Additional Director). Past directors included Ramalingam Thiyagarajan. It holds ₹13.50 Cr open charges and ₹10.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Door No 22C, Flat No 17, 5Th Cross, Anand Nagar, Phase-2,, Hosur, Tamil Nadu, 635126.
U33309TN2020PTC138368
138368
03 October 2020
₹3.50 Cr
₹3.50 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Asilomed Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohammed Farook Yasar Arabath | Additional Director | 08 Aug 2023 | Current |
| Vingnanamurthy Silambarasan | Additional Director | 08 Aug 2023 | Current |
| Govindasamy Dharmalingam | Additional Director | 08 Aug 2023 | Current |
| Rajagopal Duraisamy | Director | 06 Oct 2020 | Current |
| Ravikumar Ramalingam | Director | 03 Oct 2020 | Current |
| Elangoveera Balakrishnan | Additional Director | 06 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Asilomed Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 6235.93% increase. The company also saw a substantial improvement in profitability, with a 24.23% increase in profit. The company's net worth dipped by a decrease of 4.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Asilomed's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹135,000,000.00
₹100,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Oct 2023 | Axis Bank Limited | ₹13.50 Cr | Open |
| 09 Mar 2022 | Others | ₹5.00 Cr | Satisfied |
| 09 Mar 2022 | Others | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Asilomed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Asilomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asilomed's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Elangoveera Balakrishnan was appointed as a Additional Director was appointed as a Additional Director on 06 Aug 2025 & has been associated with this company since 4 months 15 days . was completed.
The activity A charge with Axis Bank Limited of Rs. 13.50 Cr registered on 17 Oct 2023 with Charge ID 100810348 was modified on 24 Jan 2025. was completed.
Asilomed Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on A charge registered on 09 Mar 2022 via Charge ID 100545790 with Others was fully satisfied on 08 Apr 2024. was documented.
A charge registered on 09 Mar 2022 via Charge ID 100544756 with Others was fully satisfied on 08 Apr 2024. was recorded as a recent event.
Asilomed Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
The CIN of Asilomed Private Limited is U33309TN2020PTC138368.
Asilomed Private Limited is headquartered at Door No 22C, Flat No 17, 5Th Cross, Anand Nagar, Phase-2,, Hosur, Tamil Nadu, 635126.
Asilomed Private Limited was incorporated on 03 October 2020.
The current directors of Asilomed Private Limited are
The primary industry of Asilomed Private Limited is Manufacturing.
Asilomed Private Limited is unlisted.
The authorized capital of Asilomed Private Limited is ₹3.50 Cr, and the paid-up capital is ₹3.50 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX